In this episode, we discuss the remarkable evolution of allergy and immunology through the lens of a career spanning six decades. Past AAAAI President Phil Lieberman, MD, FAAAAI, explores the pivotal scientific breakthroughs in the field starting with the discovery of IgE as he started in practice and taking us through target therapy has changed the lives of his patients. Dr. Lieberman offers us both historical perspective and guidance for physicians just starting in the field. 

Find out more about Dr. Lieberman. 

Climate change is reshaping the landscape of allergy and immunology in ways that directly affect human health. In this episode, Jeffrey G. Demain, MD, FAAAAI, discusses how rising temperatures, shifting weather patterns and increased carbon dioxide levels are intensifying allergic diseases and altering immune responses worldwide.

AAAAI President Carla Davis, MD, FAAAAI, discusses her journey in allergy / immunology including key mentors and the initiatives in education, research and advocacy that she will be advancing over the next year. Learn how you can access education tailored to your interests through AAAAI Ignite and advocate for your patients through AAAAI Advocate.

AAAAI Advocate

Alpha-gal syndrome has transformed our understanding of food allergy, linking tick bites to delayed anaphylaxis to mammalian meats. In this episode, we explore the epidemiology, immunologic mechanisms, diagnosis and management of alpha-gal syndrome with expert Scott Commins, MD, FAAAAI. Join us for practical clinical pearls and emerging insights into this unique disease.

Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™.

Find out more about alpha-gal.

GLP-1 agonists have been blockbuster medications in diabetes and obesity but they may also have a surprising role in the treatment of asthma. Join the conversation as Katherine Cahill, MD, FAAAAI, discusses how GLP-1 agonists may improve asthma control and reduce airway inflammation.

Find out more about asthma. 

Vaccines are a cornerstone of public health, training the immune system to prevent infectious diseases, especially in our most vulnerable patients. In this episode, John Kelso, MD, FAAAAI, reviews recent vaccine developments, including the importance of measles vaccination amid ongoing outbreaks, updates to vaccination schedules, considerations when using vaccines with biologics and evaluation of vaccine allergy. Join us for a practical review of key vaccine updates to help you protect your patients.

 Find out more about the importance of vaccinations across age groups. 

Improving access to penicillin allergy evaluation for millions of older patients would lead to better antibiotic treatment, decreased surgical site infections and fewer cases of C. diff. The Penicillin Allergy Verification and Evaluation Act has the potential to do just this. Priya Bansal, MD, FAAAAI, and Allison Ramsey, MD, FAAAAI, share their valuable insight into the Act and how we can make advocacy a part of our practice. 

Find out more about the Penicillin Allergy Verification and Evaluation Act

Julie Wang, MD, FAAAAI, shares highlights of the upcoming AAAAI Annual Meeting taking place in Philadelphia, Pennsylvania from February 27 to March 2. Listen in to hear what is in store this year as well as highlights such as the symposium on Philadelphia’s vaccine legacy as well as use of Artificial Intelligence and the new Practice Management Course.

Visit the AAAAI Annual Meeting website.

As immunosuppressive therapies for cancer and autoimmune disease become more common, secondary immune deficiency is increasingly encountered in clinical practice. In this episode, Sara Barmettler, MD, FAAAAI, discusses the causes, diagnosis and management of secondary immune deficiency to help allergy and immunology physicians care for these patients effectively.

Join hereditary angioedema expert Aleena Banerji, MD, FAAAAI, for a discussion about the diagnosis and management of hereditary angioedema, focusing on treatment developments that have dramatically improved the care of patients with HAE.

Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™

Find out more about hereditary angioedema.

US Hereditary Angioedema Association